CD22LB

Kyle D Apley1, Amber S Griffith2, Grant M Downes3

  • 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.

Bioconjugate chemistry
|October 26, 2023
PubMed
概括

针对抗胰岛素B细胞的新双功能分子对预防1型糖尿病 (T1D) 有望. 单体结合物减少了致病性B细胞的激活,而不会损害正常细胞,这表明了潜在的新疗法.